|
|
||||||||
Ann Thorac Surg 1998;66:1869-1871
© 1998 The Society of Thoracic Surgeons
a Department of Thoracic Surgery, Marmara University Hospital, P.K. 97 Acibadem, Istanbul, Turkey
To the Editor
The report by Dr Ducrocq and colleagues [1] underlines the prognostic factors of typical bronchial carcinoids and clearly discusses the effectiveness of resection for the treatment of bronchial carcinoids. Dr Martini also emphasized that with the goal of maximal preservation of functional lung tissue, surgery is the only effective treatment for bronchial carcinoids, even in the presence of lymph node metastases.
However, recent improvements in bronchoscopic techniques, such as Nd:YAG laser and photodynamic therapy, facilitate tumor necrosis of several millimeters in depth [2]. In a recent article by Dr Sutedja and associates [3], 6 of the 11 patients with bronchial carcinoids had received Nd:YAG laser treatment and another 1 patient had received Nd:YAG laser plus photodynamic therapy. These bronchoscopic interventions had resulted in excellent local control with surgical proof of cure. According to these results, it was concluded that endoscopic removal may become a tissue-sparing alternative for bronchoplastic surgery in a subset of patients with intraluminal typical carcinoids in the near future.
Can the bronchoscopic interventions really be an alternative to surgery for the treatment of bronchial carcinoids in the near future? We are interested in reading the authors comments on this subject.
References
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |